News

Translate this page RSS Share this page Print this page

SEARCH CRITERIA

DATE RANGE
to
 
John Shakow to Speak on Webinar About HRSA Final Rule for 340B


14 Feb 2017
THOUGHT LEADERSHIP

Washington, D.C., FDA and Life Sciences partner John Shakow will be the featured speaker on a Feb. 14 webinar titled, “HRSA Final Rule for 340B: New Requirements For Calculating Ceiling Prices & the New Reality of Civil Monetary Penalties.” The Q1 Productions webinar will address:

  • Key elements and definitions in the Final Rule, including the potential for retroactive application of penalties
  • Methods for calculating 340B ceiling prices, including the codification of penny pricing
  • Situational analysis of how new drug pricing will work in practice
  • The threat of CMPs, how they will be calculated, and under what circumstances they will be imposed by OIG
  • Other important takeaways for manufacturers’ compliance in 340B

More information can be found here.

PEOPLE

OFFICES
Washington, D.C.